RxDoctor Payments Data

Toby Christie-Perkins, DO

Family Medicine · Morris, MNNPI 1538493176

Payments from drug & device makers

$137in general payments, 2019–2025

Across 10 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$26
  • Medtronic$19
  • Teva Pharmaceuticals USA, Inc.$17
  • E.r. Squibb & Sons, L.L.C.$16
  • Novartis$15
  • Sun Pharmaceutical Industries Inc.$13
  • plus $31 from 3 others

What the payments were for

  • Food & beverage$137100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$137 in reported general payments places this provider in the 70th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$2,994
Medicare patients
18
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban118$80,102
OzempicSemaglutide43$47,821
XareltoRivaroxaban61$41,456
JardianceEmpagliflozin37$40,965
JanuviaSitagliptin Phosphate28$25,903
Tresiba Flextouch U-200Insulin Degludec14$14,516
Tresiba Flextouch U-100Insulin Degludec17$10,585
TradjentaLinagliptin12$6,456
MyrbetriqMirabegron12$5,394
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$4,351
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$3,026
CelexaCitalopram Hydrobromide11$3,010
Metoprolol Succinate273$3,005
Atorvastatin Calcium433$2,888
Icosapent Ethyl12$2,863

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$26$47,82143 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,162 family medicine providers in Minnesota.

Other family medicine in Morris

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →